Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

Author： Bedlack Richard S Traynor Bryan J Cudkowicz Merit E

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.2, 2007-05, pp. : 229-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis

By Morren John A Galvez-Jimenez Nestor

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 297-320

Informa Healthcare

Access to resources Recommend Favorite

Emerging disease modifying therapies for multiple sclerosis

By Waubant Emmanuelle

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 145-161

Informa Healthcare

Access to resources Recommend Favorite

First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis: A Comprehensive Overview

By Johnston Jessica

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1195-1211

Adis International

Access to resources Recommend Favorite

The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment

By Phillips C.J.

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 561-574

Adis International

Access to resources Recommend Favorite

Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 512-519

Bentham Science Publishers

Access to resources Recommend Favorite